AIM ImmunoTech Inc.
NYSE · CIK 0000946644 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$22,000
Operating Income
$-2.2M
Net Income
$-3.0M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $22,000 | - | - |
| Operating Income | $-2.2M | - | - |
| Net Income | $-3.0M | - | - |
| Eps Basic | -0.69 | - | - |
| Eps Diluted | -0.69 | - | - |
| Cash And Equivalents | $5.8M | - | - |
| Total Assets | $8.6M | - | - |
| Total Liabilities | $6.5M | - | - |
| Shareholders Equity | $2.1M | - | - |
| Operating Cash Flow | $-2.7M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | AIM ImmunoTech Inc. | 2026-05-15 | 0001493152-26-023750 |
| 10-K | AIM ImmunoTech Inc. | 2026-03-27 | 0001493152-26-013301 |
| 4 | AIM ImmunoTech Inc. | 2026-03-16 | 0001493152-26-010334 |
| 4 | AIM ImmunoTech Inc. | 2026-03-16 | 0001493152-26-010332 |
| 4 | AIM ImmunoTech Inc. | 2026-02-06 | 0001493152-26-005620 |
| 10-Q | AIM ImmunoTech Inc. | 2025-11-17 | 0001493152-25-023894 |
| 10-Q | AIM ImmunoTech Inc. | 2025-08-14 | 0001493152-25-011986 |